Non-Hodgkin Lymphoma
Accentia's Stock Listing Upgraded to OTCQB(TM) Market
Published in Cancer Law Weekly, September 4th, 2010
Accentia Biopharmaceuticals, Inc. (OTCQB: ABPIQ) announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Accentia filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization. Launched in April 2010, the OTCQB is a new market tier for OTC-traded U.S. companies that are registered and reporting with the SEC.
As a result of Accentia's new OTCQB designation, investors can now view real-time stock quotes with market depth (Level 2)....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2010-09-04)
More Articles from Cancer Law Weekly
- Catenins
An IRCM researcher pinpoints the cellular mechanism responsible for modulating the permeability of blood vessels - Yale University
Ancient Chinese herbal recipe eases side effects of chemotherapy - Immunization
Back-to-School Checklist Should Include Ensuring Vaccinations are Up-to-Date - Colorectal Research
Neogenix Oncology Receives Patent for DNAs Encoding Its NPC-1 Antibody, Further Expanding Patent Portfolio - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
